Tag: "enzastaurin" at medical news

Targeted, oral agent Enzastaurin shows favorable results

...were gathered from a multicenter Phase II study of enzastaurin as a second- or third-line treatment of NSCLC (ASC...logy platform leader for Lilly. Our objective with enzastaurin is to continue investigating the efficacy and safety of this unique molecule in order to determine t...

Making science personal: Lilly Oncology to unveil 76 studies at ASCO 2007

...Enzastaurin Phase II Data of Targeted, Oral Agent enzastaurin in Second- & Third-line NSCLC Abstract # 7543: June 2, 2007; 8:00 a.m. A phase II study of enzastaurin as second- or third-line treatment of non-small cell lung cancer (NSCLC) ...

1

(Date:4/14/2015)... NEW YORK , April 14, 2015 /PRNewswire/ ... Fast IDentity Online (FIDO ® ) Alliance tm ... standards-based specifications. FIDO members commit to share technology ... authentication methods that are interoperable, more secure and ... specifications enable biometric identity verification that protects sensitive ...
(Date:4/13/2015)... , April 13, 2015 ... Research, "Global Biometrics Market Forecast & Opportunities, 2020", the ... CAGR of around 14% till 2020. The biometrics ... large scale implementation and review of biometric management ... of new products with greater efficiency, are resulting ...
(Date:4/10/2015)... , April 10, 2015 Research ... of the "Security Competitive Profiles - NEC" ... , NEC will continue to supply a ... the market, with a company focus on the development ... Winning opportunities in the Asia-Pacific ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NEC Security Competitive Profile 2015 2
Other Tags
spotsdangerbeginwilextrendupwardpredisposingemphasiseditspreeclampsiadiagnoseurinesheddingfinkstrikesleaner